Promote Apoptosis of Activated Neutrophils Interleukin-8 Production but Do Not Fourteen-Member Macrolides Suppress

[1]  N. Mukaida,et al.  Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice , 2001, Clinical and experimental immunology.

[2]  H. Yamamoto,et al.  Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. , 2001, American journal of respiratory cell and molecular biology.

[3]  V. Fadok,et al.  A receptor for phosphatidylserine-specific clearance of apoptotic cells , 2000, Nature.

[4]  A. Kumatori,et al.  Eosinophil-specific Regulation of gp91 phox Gene Expression by Transcription Factors GATA-1 and GATA-2* , 2000, The Journal of Biological Chemistry.

[5]  C. Haslett.  Granulocyte apoptosis and its role in the resolution and control of lung inflammation. , 1999, American journal of respiratory and critical care medicine.

[6]  T. Hirayama,et al.  Identification and characterization of the Aeromonas sobria hemolysin glycoprotein receptor on intestine 407 cells. , 1999, Microbial pathogenesis.

[7]  C. Haslett,et al.  NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro* , 1999, The Journal of Biological Chemistry.

[8]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[9]  S. Kudoh,et al.  Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. , 1998, American journal of respiratory and critical care medicine.

[10]  E. Chi,et al.  Neutrophil apoptosis in the acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[11]  T. Kohyama,et al.  Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[12]  G. Cox,et al.  Dexamethasone‐induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis , 1997, Journal of leukocyte biology.

[13]  J. Marshall,et al.  Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. , 1997, Journal of immunology.

[14]  K. Aoshiba,et al.  Erythromycin shortens neutrophil survival by accelerating apoptosis , 1995, Antimicrobial agents and chemotherapy.

[15]  K. Matsushima,et al.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases , 1994, Infection and immunity.

[16]  K. Matsushima,et al.  Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. , 1994, The Journal of biological chemistry.

[17]  C. Haslett,et al.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators , 1993, Journal of leukocyte biology.

[18]  J Savill,et al.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. , 1992, The Journal of clinical investigation.

[19]  R. Crystal,et al.  Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. , 1992, The Journal of clinical investigation.

[20]  S. Kudoh,et al.  [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. , 1987, Nihon Kyobu Shikkan Gakkai zasshi.

[21]  H. Saito,et al.  Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. , 2000, American journal of respiratory cell and molecular biology.

[22]  H. Mukae,et al.  A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. , 1993, The American review of respiratory disease.

[23]  Eriko Yamaguchi,et al.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. , 1991, Respiration; international review of thoracic diseases.

[24]  S. Nakaike,et al.  [Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis]. , 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[25]  S. Kira,et al.  Diffuse Panbronchiolitis: A Disease of the Transitional Zone of the Lung , 1983 .